Ethan Jorgensen-Earp

Ethan Jorgensen-Earp is a member of the firm's Public Policy & Regulation Group and a Washington, D.C., senior policy advisor with a decade of experience in policy development and government affairs, with a strong focus on healthcare and appropriations. He develops and executes legislative and regulatory strategies for the firm's nonprofit and private sector clients, and has extensive experience in coalition building, strategy and alliance development, and strategic communications.

Mr. Jorgensen-Earp's work has a heavy focus on furthering individual and coalition efforts on a wide range of legislative and regulatory healthcare issues, assisting clients in the development of legislative and regulatory strategies, and communicating those strategies clearly before Congress and relevant agencies, including the U.S. Food and Drug Administration (FDA), U.S. Department of Health and Human Services (HHS) Assistant Secretary for Preparedness and Response (ASPR), National Institutes of Health (NIH) and Centers for Medicare and Medicaid Services (CMS). Mr. Jorgensen-Earp has vast knowledge and experience working with FDA-regulated products, including prescription and over-the-counter (OTC) drugs, cosmetics, medical devices, biosimilars, diagnostics and rare disease therapies, and assists clients in lobbying Congress and the Administration regarding the specific products and the frameworks under which they are regulated. He also particularly strong focus in positioning clients with emerging healthcare technologies, including medical countermeasures, diagnostic tests, digital/artificial intelligence/machine learning technologies and others, in front of relevant agencies such as ASPR, NIH and the Biomedical Advanced Research and Development Authority (BARDA) to further the development and uptake of these technologies. Mr. Jorgensen-Earp also consults with clients on a wide array of healthcare topics, including emergency medical services (EMS), Medicare/Medicaid policies, rural health and health information technology (IT), among others.

In addition, Mr. Jorgensen-Earp has significant experience with the federal appropriations process and has strong relationships with key members of the House and Senate Appropriations Committees and their staff. He has assisted clients in understanding how federal funding flows to various programs as well as developing strategies that help clients achieve their policy and funding goals in front of multiple appropriations subcommittees, including those that fund FDA, HHS and the U.S. Department of Commerce.

Prior to joining Holland & Knight, Mr. Jorgensen-Earp served as a federal lobbyist for the American Academy of Pediatrics (AAP), where he represented the organization before Congress and the Administration. In this role, he helped craft the AAP's legislative and regulatory positions on numerous issues, including drug and medical device regulation, subspecialty healthcare, adolescent health and federal research programs, among others. Mr. Jorgensen-Earp also aided in the development of the legislative and regulatory agenda of the Pediatric Policy Council (PPC), a consortium of academic pediatric associations. While working with the AAP and PPC, he utilized his experience in coalition building, especially with medical provider groups and subspecialty organizations.

Before joining the AAP, Mr. Jorgensen-Earp served as a research associate in the Transformation Center at America's Essential Hospitals (AEH). He performed research on numerous issues related to healthcare quality initiatives and implementation of Affordable Care Act (ACA) provisions in hospitals and health systems catering primarily to the Medicaid population.

Prior to AEH, Mr. Jorgensen-Earp gained experience in secondary and post-secondary education policy serving as a college advisor with AmeriCorps in southern Virginia. He also served as an intern for Sen. Mark R. Warner (D-Va.).